30 clinical trials matched your search for Solid Tumors. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Solid Tumors Study of Drug Alone and In Combination with Nivolumab in Advanced Solid Tumors Brian Henick, MD
Solid Tumors Study of ASTX295 in Patients With Solid Tumors Fabio Iwamoto, MD
Solid Tumors A Study of XmAb23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) Mark Stein, MD
Cancer A Study for Patients with Advanced Melanoma, Solid Tumors or Lymphoma Using Study Drug Pembrolizumab Nobuko Hijiya, MD
Cancer Study of IDE196 in Patients with Solid Tumors Shaheer Khan, DO
Cancer Study of A Vaccine Targeting Shared Neoantigens in Subjects with Advanced Solid Tumors Brian Henick, MD
Cancer Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors Nobuko Hijiya, MD
Cancer Study of AMG510 in Subjects with Advanced Solid Tumors Benjamin Herzberg, MD
Cancer TCR-engineered T Cells in Solid Tumors (ACTengine) Ran Reshef, MD
Cancer Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors Catherine Shu, MD
Cancer Study of ST101 in Patients with Advanced Solid Tumors Fabio Iwamoto, MD
Cancer A Study of ASP9801 in Patients With Advanced Metastatic Solid Tumors Matthew Ingham, MD
Cancer A Study of BMS-986340 Alone and in Combination With Nivolumab in Participants With Advanced Solid Tumors Shaheer Khan, DO
Cancer Study of Investigational Drug (RP-6306) in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of BAY 1895344 in Combination with Chemotherapy for Patients with Advanced Cancer Mark Stein, MD
Cancer Study of IDE397 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Cancer Study of CS5001 in Patients with Advanced Solid Tumors Shaheer Khan, DO
Cancer Study of RP-6306 in Combination with FOLFIRI in Patients with Advanced Solid Tumors (Colon, Esophageal, or GI Cancer) Ryan Moy, MD
Cancer Study of STK-012 Alone or in Combination with Pembrolizumab (KEYTRUDA) in Patients with Advanced Solid Tumors Benjamin Izar, MD
Cancer Study of BLU-222 Alone or in Combination with Other Cancer Therapy for Patients with Advanced Cancer Brian Henick, MD
Cancer Study of RMC-6291 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Gynecologic Cancer Study of SL-172154 in Combination with PLD or MIRV in Patients with Ovarian Cancer June Hou, MD
Cancer Study of ASKG915 in Patients with Advanced Solid Tumors Mark Stein, MD
Cancer Study of XL092 Alone or in Combination with Anticancer Therapy in Patients with Unresectable orMetastatic Solid Tumors Karie D. Runcie, MD
Cancer Study of MRT-2359 in Patients with Solid Tumors Benjamin Herzberg, MD
Cancer Study of RMC-6236 in Patients with Solid Tumors with a KRAS Mutation Benjamin Herzberg, MD
Gynecologic Cancer Study of ZN-c3 in Patients with Solid Tumors with MRE11, RAD50, NBN, or CCNE1 Gene Mutations June Hou, MD
Breast Cancer Study of RLY-2608 in Patients with Breast Cancer Julia McGuinness, MD
Cancer Study of ASP3082 in Patients with Advanced Cancer with a KRAS G12D Mutation Benjamin Herzberg, MD
Cancer Study of 68Ga-FAP-2286 and 177Lu-FAP-2286 in Patients with Advanced Cancer Ryan Moy, MD